WEST PHARMACEUTICAL SERVICES INCWST

Market cap

$19.5B

P/E ratio

	Dec 31, 2010	Dec 31, 2012	Dec 31, 2013	Dec 31, 2014	Dec 31, 2015	Dec 31, 2016	Dec 31, 2017	Dec 31, 2018	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Cash and cash equivalents	110	162	230	255	275	203	236	337	439	616	763	894	854	485
Accounts receivable, net	126	175	186	179	181	201	253	288	319	385	489	507	512	553
Inventories	147	162	177	182	181	199	215	215	236	321	378	415	435	377
Other current assets	43	38	35	36	37	39	39	54	65	52	112	103	136	124
Total current assets	437	557	651	659	674	642	744	894	1,059	1,374	1,742	1,920	1,936	1,538
Property, plant and equipment	1,077	1,275	1,369	1,391	1,440	1,555	1,746	1,753	1,820	2,036	2,215	2,387	2,738	2,986
Less: accumulated depreciation and amortization	522	606	657	685	719	776	891	931	981	1,092	1,158	1,228	1,325	1,404
Property, plant and equipment, net	555	669	712	706	721	778	855	822	839	943	1,058	1,158	1,413	1,582
Operating lease right-of-use assets	-	-	-	-	-	-	-	-	70	68	69	104	99	105
Investments in affiliated companies	48	60	61	61	61	83	86	91	193	215	208	205	210	202
Goodwill	113	113	114	109	105	103	108	106	108	111	110	107	109	106
Intangible assets, net	55	51	48	42	38	23	22	20	30	31	23	18	15	11
Deferred income taxes	-	-	-	-	-	-	-	-	-	16	49	66	26	26
Other noncurrent assets	23	25	24	29	26	21	23	21	25	23	39	38	21	74
Total Assets	1,294	1,564	1,672	1,671	1,695	1,717	1,863	1,979	2,341	2,794	3,314	3,617	3,830	3,643
Notes payable and other current debt	-	-	-	-	-	-	-	-	2	2	44	2	134	-
Accounts payable	63	103	108	103	120	122	138	130	157	213	232	215	242	239
Accrued salaries, wages and benefits	-	-	-	-	-	-	-	-	73	106	116	77	106	74
Income taxes payable	5	16	14	15	13	5	6	10	6	26	26	25	17	32
Operating lease liabilities	-	-	-	-	-	-	-	-	10	10	9	16	18	18
Other current liabilities	41	44	43	52	54	58	77	77	91	144	163	182	155	188
Total current liabilities	170	262	237	253	314	241	280	284	342	503	594	519	672	550
Long-term debt	358	379	371	310	229	226	197	196	255	253	209	207	73	203
Deferred income taxes	-	-	-	-	-	-	-	-	-	10	5	14	13	21
Pension and other postretirement benefits	87	135	83	84	62	76	53	56	53	58	41	28	30	28
Operating lease liabilities	-	-	-	-	-	-	-	-	62	60	63	93	85	82
Deferred compensation benefits	-	-	-	-	-	-	-	-	-	23	29	19	19	15
Other long-term liabilities	34	38	55	53	54	47	43	34	41	32	38	52	59	62
Total Liabilities	669	835	765	714	671	599	583	583	768	939	978	932	949	961
Preferred Stock, Value, Issued	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Common Stock, Value, Issued	9	9	18	18	18	18	19	19	19	19	19	19	19	19
Additional Paid in Capital	77	79	120	160	208	260	309	282	273	267	249	232	120	22
Retained earnings	613	720	805	902	965	1,072	1,178	1,353	1,549	1,847	2,457	2,988	3,523	3,957
Accumulated other comprehensive loss	-31	-76	-32	-119	-163	-187	-117	-154	-150	-111	-160	-183	-144	-258
Treasury stock, at cost (3.0 million and 1.8 million shares in 2024 and 2023)	-	-	-	-	-	-	-	-	-	-	-	-	638	1,057
Total Equity	626	729	906	957	1,024	1,118	1,280	1,396	1,573	1,855	2,335	2,685	2,881	2,682
Total Liabilities and Equity	1,294	1,564	1,672	1,671	1,695	1,717	1,863	1,979	2,341	2,794	3,314	3,617	3,830	3,643